What are must-haves for AI devices to be commercialized and regulated?
In a preview of their HIMSS25 panel discussion, Erik Adams of BCG and Gunnar Trommer of BCG X explain how much capital is required to develop and commercialize artificial intelligence-enabled medical devices in the U.S.
